CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 6
- ScaleMarket cap is $1.49B, above the global median of $1.18B
- FinancialsAltman Z-Score 3.24: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.43%Above 5Y avg (2.63%)
Annual Rate
EUR 1.00Paid annual
Payout Ratio
60.4%Moderate
Payback Period
21.6 yr
Last Ex-Dividend
May 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.30BEUR1.49B · vs all stocks (USD)
Trailing P/E
21.38xvs Specialty Chemicals peers
Revenue (TTM)
1.25BEUR1.44B · vs all stocks (USD)
Profit Margin
4.96%vs Specialty Chemicals peers
Beta
0.9360xvs all stocks
52-Week Change
35.25%vs all stocks
Market Capitalization
1.30BEUR1.49B · vs all stocks (USD)
Enterprise Value
1.79BEUR2.05B · vs all stocks (USD)
Trailing P/E
21.38xvs Specialty Chemicals peers
Forward P/E
14.77xvs Specialty Chemicals peers
Price to Sales (TTM)
1.04xvs Specialty Chemicals peers
Price to Book (MRQ)
1.73xvs Specialty Chemicals peers
Enterprise to Revenue
1.43xvs Specialty Chemicals peers
Enterprise to EBITDA
10.54xvs Specialty Chemicals peers
Profit Margin
4.96%vs Specialty Chemicals peers
Operating Margin
7.27%vs Specialty Chemicals peers
Return on Assets (TTM)
4.26%vs Specialty Chemicals peers
Return on Equity (TTM)
8.40%vs Specialty Chemicals peers
Revenue (TTM)
1.25BEUR1.44B · vs all stocks (USD)
Revenue per Share (TTM)
21.70EURUpdated Sep 23, 2026Quarterly Revenue Growth
-2.20%vs Specialty Chemicals peers
Gross Profit (TTM)
313.90MEUR359.65M · vs all stocks (USD)
EBITDA (TTM)
196.60MEUR225.26M · vs all stocks (USD)
Net Income (TTM)
62.20MEUR71.27M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-29.70%vs Specialty Chemicals peers
Operating Cash Flow (TTM)
144.20MEUR165.22M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-68.39MEUR-78.36M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.00EURUpdated Sep 23, 2026Trailing Annual Dividend Yield
4.43%vs all stocks
5-Year Average Dividend Yield
2.63%vs all stocks
Payout Ratio
60.38%vs Specialty Chemicals peers
Revenue
1.27BEURFY2025 · Dec 31, 2025Cost of Goods Sold
937.10MEURFY2025 · Dec 31, 2025Gross Profit
330.30MEURFY2025 · Dec 31, 2025Operating Income
116.50MEUR133.48M · vs all stocks (USD)
Pre-tax Income
94.90MEURFY2025 · Dec 31, 2025Income Tax Expense
20.10MEURFY2025 · Dec 31, 2025Net Income
74.80MEURFY2025 · Dec 31, 2025EBIT
110.80MEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
196.60MEURFY2025 · Dec 31, 2025Research & Development
42.80MEURFY2025 · Dec 31, 2025Selling, General & Administrative
171.00MEURFY2025 · Dec 31, 2025Non-operating Interest Income
4.60MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
15.90MEURFY2025 · Dec 31, 2025EPS (Basic)
1.29EURFY2025 · Dec 31, 2025EPS (Diluted)
1.27EURFY2025 · Dec 31, 2025Basic Shares Outstanding
57.99MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
57.99MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
116.50MEURFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00EURFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025Operating Cash Flow
91.50MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
44.70MEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
116.50MEURFY2025 · Dec 31, 2025Stock-based Compensation
5.20MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-14.20MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-16.00MEURFY2025 · Dec 31, 2025Purchase of Investments
-1.90MEURFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.90MEURFY2025 · Dec 31, 2025Long-term Debt Issuance
2.00MEURFY2025 · Dec 31, 2025Long-term Debt Payments
-35.30MEURFY2025 · Dec 31, 2025Common Stock Repurchase
-10.00MEURFY2025 · Dec 31, 2025Common Dividends Paid
-37.20MEURFY2025 · Dec 31, 2025Net Financing Cash Flow
-80.50MEURFY2025 · Dec 31, 2025Shares Outstanding
57.65MSharesUpdated Sep 23, 2026Float Shares
51.51MSharesUpdated Sep 23, 2026% Held by Insiders
0.22%vs all stocks
% Held by Institutions
84.91%vs all stocks
Total Cash (MRQ)
36.00MEUR41.25M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.6240EURUpdated Sep 23, 2026Total Debt (MRQ)
517.60MEUR593.05M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6849xvs Specialty Chemicals peers
Current Ratio (MRQ)
1.83xvs Specialty Chemicals peers
Book Value per Share (MRQ)
13.11EURUpdated Sep 23, 2026Total Assets
1.42BEUR1.62B · vs all stocks (USD)
Total Current Assets
580.00MEURFY2025 · Dec 31, 2025Total Liabilities
674.30MEURFY2025 · Dec 31, 2025Total Non-current Assets
836.90MEURFY2025 · Dec 31, 2025Total Non-current Liabilities
367.70MEURFY2025 · Dec 31, 2025Total Current Liabilities
306.60MEURFY2025 · Dec 31, 2025Cash
44.70MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
44.70MEURFY2025 · Dec 31, 2025Accounts Receivable
174.90MEURFY2025 · Dec 31, 2025Inventory
241.20MEURFY2025 · Dec 31, 2025Accounts Payable
109.30MEURFY2025 · Dec 31, 2025Short-term Debt
99.00MEURFY2025 · Dec 31, 2025Other Current Liabilities
96.40MEURFY2025 · Dec 31, 2025Long-term Debt
347.60MEURFY2025 · Dec 31, 2025Other Non-current Liabilities
300.00KEURFY2025 · Dec 31, 2025Common Stock (Book)
14.80MEURFY2025 · Dec 31, 2025Retained Earnings
706.60MEURFY2025 · Dec 31, 2025Total Shareholders' Equity
742.60MEUR850.84M · vs all stocks (USD)
52-Week Low
16.16EURUpdated Sep 23, 202652-Week High
23.14EURUpdated Sep 23, 202652-Week Change
35.25%vs all stocks
Beta
0.9360xvs all stocks
50-Day MA
20.34EURUpdated Sep 23, 2026200-Day MA
19.67EURUpdated Sep 23, 2026Avg 10-Day Volume
152.52KSharesUpdated Sep 23, 2026Avg 30-Day Volume
121.47KSharesUpdated Sep 23, 2026Diluted EPS (TTM)
1.06EURUpdated Sep 23, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.24: safe zoneNotable
Altman Z-Score: 3.24
Supply Chain
Downstream position: depends on 10 industries, supplies 6Notable
Outgoing: 6.00Incoming: 10.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Market cap is $1.49B, above the global median of $1.18BNotable
Market cap (USD): 1,490,205,046.398Global Median: 1,180,223,658.953
Revenue is $1.44B, above the global median of $548.88MNotable
Revenue (USD): 1,435,522,667.336Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
Azenta, Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Kirloskar Brothers Limited
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Eaglerise Electric & Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Rainbow Children's Medicare Pvt. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Triangle Tyre Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
JBM Auto Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suzhou Anjie Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlow
Ardent Health Partners Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Sino Geophysical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Datang Telecom Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Harmony Biosciences Holdings, Inc.
1 interpretationIndustry-Benchmarked Return on Capital Elevated
Ennis Inc.
1 interpretationIndustry-Benchmarked Return on Capital Elevated
The Toro Company
1 interpretationIndustry-Benchmarked Return on Capital Elevated
Supply Chain
Petrochemicals Supply Chain
Follow hydrocarbons through cracking, separation, polymers, conversion, use, and recovery. A cracker produces a coupled slate, so feedstock, product demand, contracts, plant configuration, and waste routes constrain one another.
Plastics Supply Chain
Follow feedstock through monomer and polymer production, compounding, conversion, packaging, use, collection, recycling, combustion, and disposal. Resin tonnes and recycling rates are bounded measurements, not proof that the original function returned.
Natural Rubber Supply Chain
Follow natural rubber from tree and tapping through coagulation, grading, compounding, vulcanization, service, and recovery. The chain preserves some properties while closing others, and money arrives on a faster clock than a new stand of trees.